DOSAGE REGIMEN FOR MADCAM ANTAGONISTS
The present invention provides a method for the treatment of a patient comprising administering to the patient an initial dose of between about 1 mg and about 150 mg of a MAdCAM antagonist antibody. Biomarkers for assessing a patient's response to anti-MAdCAM treatment are also provided.
Saved in:
| Main Authors | , , , , , , , , , , , |
|---|---|
| Format | Patent |
| Language | English French German |
| Published |
27.07.2022
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention provides a method for the treatment of a patient comprising administering to the patient an initial dose of between about 1 mg and about 150 mg of a MAdCAM antagonist antibody. Biomarkers for assessing a patient's response to anti-MAdCAM treatment are also provided. |
|---|---|
| AbstractList | The present invention provides a method for the treatment of a patient comprising administering to the patient an initial dose of between about 1 mg and about 150 mg of a MAdCAM antagonist antibody. Biomarkers for assessing a patient's response to anti-MAdCAM treatment are also provided. |
| Author | CATALDI, Fabio VINCENT, Michael Steven AHMAD, Alaa TILLEY, Mera Krishnan BANERJEE, Anindita COMER, Gail M VON SCHACK, David J CLARE, Robert A PRADHAN, Vivekananda PAGE, Karen Michelle HASSAN-ZAHRAEE, Mina ZHANG, Weidong |
| Author_xml | – fullname: HASSAN-ZAHRAEE, Mina – fullname: ZHANG, Weidong – fullname: TILLEY, Mera Krishnan – fullname: PRADHAN, Vivekananda – fullname: COMER, Gail M – fullname: VINCENT, Michael Steven – fullname: BANERJEE, Anindita – fullname: CATALDI, Fabio – fullname: PAGE, Karen Michelle – fullname: AHMAD, Alaa – fullname: CLARE, Robert A – fullname: VON SCHACK, David J |
| BookMark | eNrjYmDJy89L5WRQdfEPdnR3VQhydff0dfVTcPMPUvB1dHF29FVw9AtxdPf38wwOCeZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAcZGJkZmFiZOhsZEKAEAKdEkfQ |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | RÉGIME POSOLOGIQUE POUR ANTAGONISTES DE MADCAM DOSIERUNGSSCHEMA FÜR MADCAM-ANTAGONISTEN |
| ExternalDocumentID | EP3242684B1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_EP3242684B13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Oct 04 05:01:02 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French German |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_EP3242684B13 |
| Notes | Application Number: EP20160702586 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220727&DB=EPODOC&CC=EP&NR=3242684B1 |
| ParticipantIDs | epo_espacenet_EP3242684B1 |
| PublicationCentury | 2000 |
| PublicationDate | 20220727 |
| PublicationDateYYYYMMDD | 2022-07-27 |
| PublicationDate_xml | – month: 07 year: 2022 text: 20220727 day: 27 |
| PublicationDecade | 2020 |
| PublicationYear | 2022 |
| RelatedCompanies | Pfizer Inc |
| RelatedCompanies_xml | – name: Pfizer Inc |
| Score | 3.4176998 |
| Snippet | The present invention provides a method for the treatment of a patient comprising administering to the patient an initial dose of between about 1 mg and about... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | DOSAGE REGIMEN FOR MADCAM ANTAGONISTS |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220727&DB=EPODOC&locale=&CC=EP&NR=3242684B1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH-MKepNp-L8IgftrVhrm3aHIm3SbhP6wVZlt2HaFHaZw1X8932p3fSit5DAS_Lg5f3eZwBuKlpIWhaFTqkY6FZJqa5QtS4HpdU01HK_s3wTOnq2nmb2rAOLTS1M0yf0s2mOiBJVoLzXzXu9-nFi8Sa3cn0nFjj19hjlHtda69g0DdTHGg-8MEt5yjTGcKQlE0_hBupaARpKO4iiHZX9Fb4Eqihl9VujRIewmyGxZX0EHbnswT7bfLzWg724jXfjsBW99THc8lRFf8gkHI7jMCFovZHY58yPiZ_k_jBNxtN8egIkCnM20nG_-fZu8zDbnuzhFLpo8sszIEIUZeVSx6xeDcsRhqBSILKhCOYs25b3fej_Seb8n7ULOFBMUr5J07mEbv3-Ia9QqdbiumHHF0wZdvM |
| link.rule.ids | 230,309,783,888,25578,76884 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLamgRg3GCDGswforaKUNu0OFepzLawPbQXtVi1tKu0yJlbE38cp3eACNyuRnMSS48927ADcVKRgpCwKiRA6lNSSEImjaokNS7VpqGV8v_KNSfCiPs20WQcWm1qYpk_oZ9McETWqQH2vm_t69RPEcpu3les7usCht0c_M12x9Y4VRUZ7LLq26aWJmzii4yAlxhOT4wZiqDY6SjuIsA3eZt97tXlRyuq3RfEPYDdFZsv6EDps2Yees_l4rQ97UZvvRrJVvfUR3LoJz_4IE28URl4soPcmRJbrWJFgxZk1SuJwmk2PQfC9zAkkXC_fni330u3OHk6giy4_OwWB0qKsDKIr1VxWdSpTwigiG4JgTtU0dj-AwZ9szv6Zu4ZekEXjfBzGz-ewzwXG45SKfgHd-v2DXaKBrelVI5ovBz954w |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=DOSAGE+REGIMEN+FOR+MADCAM+ANTAGONISTS&rft.inventor=HASSAN-ZAHRAEE%2C+Mina&rft.inventor=ZHANG%2C+Weidong&rft.inventor=TILLEY%2C+Mera+Krishnan&rft.inventor=PRADHAN%2C+Vivekananda&rft.inventor=COMER%2C+Gail+M&rft.inventor=VINCENT%2C+Michael+Steven&rft.inventor=BANERJEE%2C+Anindita&rft.inventor=CATALDI%2C+Fabio&rft.inventor=PAGE%2C+Karen+Michelle&rft.inventor=AHMAD%2C+Alaa&rft.inventor=CLARE%2C+Robert+A&rft.inventor=VON+SCHACK%2C+David+J&rft.date=2022-07-27&rft.externalDBID=B1&rft.externalDocID=EP3242684B1 |